Home/Pipeline/esolution

esolution

Esophageal protection during atrial fibrillation ablation

ApprovedActive

Key Facts

Indication
Esophageal protection during atrial fibrillation ablation
Phase
Approved
Status
Active
Company

About S4 Medical

S4 Medical has developed and commercialized the esolution device, a novel medical device that physically moves the esophagus away from the heart during cardiac ablation for atrial fibrillation, thereby mitigating a serious procedural complication. The device is distinguished by its compatibility with any ablation energy source and mapping system, offering procedural flexibility without requiring new capital equipment. With FDA clearance and a targeted value proposition of improved safety and procedural efficiency, the company is positioned to address a significant unmet need in the growing electrophysiology device market. Its leadership team combines clinical expertise in electrophysiology with seasoned commercial experience in launching disruptive cardiac technologies.

View full company profile

Therapeutic Areas